# A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: Incyte Corporation · Condition: Ovarian Cancer

- Company: Incyte Corporation
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07023627

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.